Ergo Science Corp (ERGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,034 | 596 | -2,583 | -586 | -1,251 |
| Depreciation Amortization | 3,626 | 702 | 4,429 | 5 | 10 |
| Income taxes - deferred | -130 | 88 | -330 | N/A | N/A |
| Accounts receivable | 1,168 | 914 | -1,194 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,393 | 3,893 | -72 | -239 | -56 |
| Other Working Capital | 746 | -664 | 4,065 | -288 | -45 |
| Other Operating Activity | 626 | -4,603 | -383 | 239 | 59 |
| Operating Cash Flow | $608 | $926 | $3,932 | $-870 | $-1,283 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 16,959 |
| PPE Investments | -316 | -42 | 3,427 | N/A | 2 |
| Net Acquisitions | -20,918 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-21,234 | $-42 | $3,427 | $N/A | $16,960 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | -7,606 | N/A | N/A |
| Financing Cash Flow | $N/A | $N/A | $-7,606 | $N/A | $N/A |
| Exchange Rate Effect | 0 | 93 | 61 | N/A | N/A |
| Beginning Cash Position | 27,846 | 733 | 919 | 25,808 | 10,131 |
| End Cash Position | 7,220 | 1,710 | 733 | 24,938 | 25,808 |
| Net Cash Flow | $-20,626 | $977 | $-186 | $-870 | $15,677 |
| Free Cash Flow | |||||
| Operating Cash Flow | 608 | 926 | 3,932 | -870 | -1,283 |
| Capital Expenditure | -316 | -46 | -474 | N/A | N/A |
| Free Cash Flow | 292 | 880 | 3,458 | -870 | -1,283 |